Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Dec 14, 2013; 19(46): 8527-8530
Published online Dec 14, 2013. doi: 10.3748/wjg.v19.i46.8527
Published online Dec 14, 2013. doi: 10.3748/wjg.v19.i46.8527
Different standards for healthy screenees than patients in routine clinics?
Geir Hoff, Department of Research and Development, Telemark Hospital, 3710 Skien, Norway
Geir Hoff, Cancer Registry of Norway, 0369 Oslo, Norway
Geir Hoff, Institute of Health and Society, University of Oslo, 0850 Oslo, Norway
Author contributions: Hoff G solely contributed to this manuscript.
Correspondence to: Geir Hoff, MD, PhD, Professor, Department of Research and Development, Telemark Hospital, Ulefossvn, 3710 Skien, Norway. hofg@online.no
Telephone: +47-91-866762 Fax: +47-22-451370
Received: September 23, 2013
Revised: October 20, 2013
Accepted: November 3, 2013
Published online: December 14, 2013
Revised: October 20, 2013
Accepted: November 3, 2013
Published online: December 14, 2013
Core Tip
Core tip: There is a basic difference in incitements to attend for screening when you are healthy and for routine clinics when you are ill. This article points out logical mechanisms which may set standards for screening higher than for routine clinics, but this may prove to be of benefit for clinical services and patients in the long run. This is highlighted by sessile serrated polyps which were previously classified as innocuous hyperplastic polyps. Recent guidelines now recommend polypectomy of these lesions for cancer prevention, but we do not know the benefit gained - only the increased risk of perforation by polypectomy.